Reply to A. Levy et al

J Clin Oncol. 2013 Jan 20;31(3):396. doi: 10.1200/JCO.2012.46.4867.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Clinical Trials, Phase I as Topic*
  • Humans
  • Molecular Targeted Therapy*
  • Neoplasms / mortality*
  • Neoplasms / pathology*
  • Tumor Burden / drug effects*

Substances

  • Antineoplastic Agents